Stamina Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$2.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$12.5M |
| 2 |
Booz Allen Hamilton
BAH
|
+$12.5M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$11.7M |
| 4 |
Cheniere Energy
LNG
|
+$9.36M |
| 5 |
Evolent Health
EVH
|
+$9.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 61.12% |
| 2 | Technology | 38.88% |
| 3 | Consumer Staples | 0% |
| 4 | Energy | 0% |
| 5 | Financials | 0% |
Similar funds
Stamina Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Stamina Capital Management held 44 positions worth $13.3M, down 93% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Stamina Capital Management withdrew a net $183M in Q4 2022, closing 41 positions and reducing 2 holdings. Its most notable exit was Booz Allen Hamilton, an estimated $12.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 61% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Stamina Capital Management opened a new position in Maxar Technologies Inc. Common Stock worth $5.17M.
- Stamina Capital Management's largest Q4 2022 buy was Maxar Technologies Inc. Common Stock: 100,000 shares worth $5.17M.
- Stamina Capital Management's biggest Q4 2022 reduction was TransDigm Group, cutting an estimated $12.5M.
- Stamina Capital Management fully exited Booz Allen Hamilton in Q4 2022, selling an estimated $12.5M.
- Stamina Capital Management's ten largest holdings make up 100% of its $13.3M portfolio in Q4 2022.
- Stamina Capital Management opened 1 new position and closed 41 in Q4 2022.
- Stamina Capital Management's portfolio value fell 93% quarter-over-quarter to $13.3M.
Based on Stamina Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.